🔎 Trials Near Me

ホーム › 過体重 › テキサス › San Antonio

San Antonio、TXにおける過体重の臨床試験

San Antonioとその周辺地域(約30マイル以内)の拠点で、過体重に関する34件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

被験者募集中第1相健康なボランティア歓迎
  • Kailera Clinical Site, San Antonio
18歳〜85歳 · 全性別 · 2026/10/01更新 · NCT07793929

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

被験者募集中第3相
  • DM Clinical, San Antonio
  • The Texas Liver Institute, San Antonio
  • Pinnacle Clinical Research, San Antonio
  • 他1件
8歳〜18歳 · 全性別 · 2026/09/30更新 · NCT07253285

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

被験者募集中第1相
  • Endeavor Clinical Trials, San Antonio
18歳〜65歳 · 全性別 · 2026/09/28更新 · NCT07399678

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

被験者募集中第3相
  • Sleep Therapy Research Center, San Antonio
18歳以上 · 全性別 · 2026/09/28更新 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

被験者募集中第3相
  • IMA Clinical Research San Antonio, San Antonio
  • VIP Trials, San Antonio, TX 78230
  • Consano Clinical Research, LLC, Shavano Park · 12マイル先
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

被験者募集中第3相
  • VIP Trials, San Antonio
18歳以上 · 全性別 · 2026/09/28更新 · NCT07595549

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

被験者募集中第3相
  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

被験者募集中第3相
  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

被験者募集中第3相
  • IMA Clinical Research San Antonio, San Antonio
18歳以上 · 全性別 · 2026/09/22更新 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

被験者募集中第3相
  • IMA Clinical Research San Antonio, San Antonio
  • Endeavor Clinical Trials, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · 12マイル先
18歳以上 · 全性別 · 2026/09/22更新 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

被験者募集中第3相
  • Research Site, San Antonio
  • Research Site, San Antonio
  • Research Site, San Antonio
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

被験者募集中第3相
  • Sleep Therapy Research Center, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · 12マイル先
18歳以上 · 全性別 · 2026/09/22更新 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

被験者募集中第3相
  • Bandera Family Health Care, San Antonio
  • Consano Clinical Research - Shavano Park, Shavano Park · 12マイル先
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

被験者募集中第3相
  • IMA Clinical Research San Antonio, San Antonio
18歳以上 · 全性別 · 2026/09/22更新 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

被験者募集中第3相
  • VIP Trials, San Antonio
  • Endeavor Clinical Trials, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · 12マイル先
18歳以上 · 全性別 · 2026/09/22更新 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

被験者募集中第2相
  • Endeavor Clinical Trials, San Antonio
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

被験者募集中第3相
  • AURORA-1 Clinical Site, San Antonio
  • AURORA-1 Clinical Site, San Antonio
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

被験者募集中第3相
  • AURORA-2 Clinical Site, San Antonio
  • AURORA-2 Clinical Site, San Antonio
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

被験者募集中第3相
  • Pinnacle Clinical Research - San Antonio, San Antonio
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

被験者募集中第2相
  • Consano Clinical Research, LLC, Shavano Park · 12マイル先
18歳〜75歳 · 全性別 · 2026/09/14更新 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

被験者募集中第3相
  • Pinnacle Clinical Research - South San Antonio, San Antonio
  • IMA Clinical Research - San Antonio, San Antonio
  • Consano Clinical Research, Shavano Park · 12マイル先
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

被験者募集中第3相健康なボランティア歓迎
  • ACCOMPLISH-2 Research Site, San Antonio
  • ACCOMPLISH-2 Research Site, San Antonio
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

被験者募集中第2相
  • Endeavor Clinical Trials, San Antonio
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

被験者募集中第2相
  • Consano Clinical Research, LLC, Shavano Park · 12マイル先
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT07215559

A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity

被験者募集中第1相健康なボランティア歓迎
  • ICON, San Antonio
18歳〜55歳 · 全性別 · 2026/09/04更新 · NCT07767175

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

被験者募集中第3相
  • Clinical Trials of Texas, San Antonio
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684235

A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

被験者募集中第1相健康なボランティア歓迎
  • ICON Early Phase Services, LLC, San Antonio
18歳〜65歳 · 全性別 · 2026/09/01更新 · NCT07654972

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

被験者募集中第3相
  • Research Site, San Antonio
18歳以上 · 全性別 · 2026/08/25更新 · NCT07784725

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight

被験者募集中第1相健康なボランティア歓迎
  • ICON Early Phase Services, San Antonio
18歳〜65歳 · 全性別 · 2026/08/20更新 · NCT07738614

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

被験者募集中第3相
  • ACCOMPLISH-1 Research Site, San Antonio
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361

他の都市における過体重の試験

San Antonioにおける他の研究

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。